Vitamin D Deficiency As a Risk Factor for the Development and Malignant Transformation of Oral Lichen Planus
1 other identifier
observational
70
1 country
1
Brief Summary
To examine how a lack of vitamin D may increase the risk of developing oral lichen planus and its malignant progression while accounting for sex, food habits, sunlight, socioeconomic level, and psychological variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2023
CompletedFirst Submitted
Initial submission to the registry
September 2, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedNovember 20, 2024
September 1, 2023
23 days
September 2, 2023
November 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
serum vitamin D level in OLP
measured by ELISA
1 month
Secondary Outcomes (3)
serum vitamin D level in correlation with sex, dietary habits and sun exposure.
1 month
serum vitamin D level in correlation with socioeconomic status
1 month
serum vitamin D level in correlation with Psychological factors
1 month
Study Arms (2)
Group A
35 OLP patients
Group B
35 healthy controls.
Interventions
Enzyme-linked immunosorbent assay (ELISA) was used following manufacturer's instructions. This test uses a competitive ELISA-based technique that was designed to quantitatively determine the concentration of 1,25-dihydroxyvitamin D3/D2 in human serum.
Eligibility Criteria
patients presenting with a clinical picture and histological findings that confirm the diagnosis of OLP (Group A) and age, sex, and dietary habits matched healthy controls (Group B).
You may qualify if:
- (Group A) patients presenting with a clinical picture and histological findings that confirm the diagnosis of OLP
- (Group B) age, sex, and dietary habits matched healthy controls.
You may not qualify if:
- (1) subjects who have been receiving any kind of VD supplements, multivitamins, or any drug that may affect VD measurements
- (2) patients with suspected restoration-related or smokeless tobacco-related lesions.
- (3) patients with any systemic medical condition or pregnant females.
- (4) patients with VD toxicity (VD≥100 ng/ml).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fayoum University
Al Fayyum, Egypt
Biospecimen
blood samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
September 2, 2023
First Posted
September 13, 2023
Study Start
August 1, 2023
Primary Completion
August 24, 2023
Study Completion
August 24, 2023
Last Updated
November 20, 2024
Record last verified: 2023-09